132 related articles for article (PubMed ID: 36624717)
1. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
[TBL] [Abstract][Full Text] [Related]
4. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
6. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
8. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
[TBL] [Abstract][Full Text] [Related]
9. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
10. Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection.
Liu CH; Liu CJ; Su TH; Huang SC; Tseng TC; Wu JH; Chen PJ; Kao JH
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359492
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
[TBL] [Abstract][Full Text] [Related]
12. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
Hur M; Park M; Moon HW; Choe WH; Lee CH
Ann Lab Med; 2022 Mar; 42(2):249-257. PubMed ID: 34635616
[TBL] [Abstract][Full Text] [Related]
15. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
[TBL] [Abstract][Full Text] [Related]
16. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease.
Tangvoraphonkchai K; Suttichaimongkol T; Kularbkaew C; Sangaimwibool P; Sukeepaisarnjaroen W
Sci Rep; 2022 Apr; 12(1):6757. PubMed ID: 35474106
[TBL] [Abstract][Full Text] [Related]
17. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
[TBL] [Abstract][Full Text] [Related]
19. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]